✦ LIBER ✦
Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy
✍ Scribed by Toni K. Choueiri; Wanling Xie; Anthony V. D'Amico; Robert W. Ross; Jim C. Hu; Mark Pomerantz; Meredith M. Regan; Mary-Ellen Taplin; Philip W. Kantoff; Oliver Sartor; William K. Oh
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 229 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.